Abstract
Tiotropium (Spiriva®) is an inhaled, once-daily anticholinergic medication for chronic obstructive pulmonary disease (COPD). We conducted a population-based cohort study to examine the risk of cardiovascular and respiratory hospitalizations and mortality with tiotropium. Using the Danish healthcare registries, we identified persons ≥40 years old in three counties who were hospitalized for COPD from 1/1/1977 to 12/31/2003. Respiratory and cardiovascular medications were assessed from dispensing records. Cox regression was used to compute incidence rate ratios (RR) and 95% confidence intervals (CI) for hospitalization and death between 1/1/2002 and 12/31/2003, associated with periods of tiotropium use compared to non-use, controlling for age, gender, time since COPD, concomitant respiratory and cardiovascular medications, prior hospitalizations and Charlson comorbidity index. Among persons with COPD (10,603), 75% were ≥60 years old. Follow-up was ≥18 months for 64%. Among those exposed to tiotropium compared to periods of non-use, the RR for total and cause-specific hospitalization endpoints were not elevated except for COPD hospitalization (RR = 1.52, 95% CI: 1.29, 1.79). Mortality endpoints included total mortality (RR = 0.77, 95% CI: 0.65, 0.91), respiratory mortality (RR = 0.79, 95% CI: 0.60, 1.04), sudden death (RR = 0.71, 95% CI: 0.21, 2.34), cardiac arrest (RR = 0.74, 95% CI: 0.42, 1.32), heart failure (RR = 0.84, 95% CI: 0.41, 1.75), and myocardial infarction (RR = 1.25, 95% CI: 0.49, 3.17). Compared to periods of non-use, tiotropium was associated with reduced respiratory and overall mortality and was not associated with increased cardiac mortality. An increase in COPD hospitalization is inconsistent with clinical trial data and suggests preferential prescribing due to disease severity.
Similar content being viewed by others
Abbreviations
- ATC:
-
Anatomical therapeutic chemical
- CI:
-
Confidence interval
- COPD:
-
Chronic obstructive pulmonary disease
- ICD:
-
International classification of disease
- IR:
-
Incidence rate
- No:
-
Number
- RR:
-
Rate ratio
- SVT:
-
Supraventricular tachycardia
References
Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R (1999) Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64:457–464
US Package insert: Tiotropium
Morganroth J, Golisch W, Kesten S (2004) Lack of cardiac signals in COPD patients receiving tiotropium as defined by electrocardiographic monitoring in placebo controlled trials J Chronic Obstruct Pulm Dis 1:181–190
Gross NJ (2006) Anticholinergic agents in asthma and COPD. Eur J Pharmacol 533(1–3):36–39
Kesten S, Jara M, Wentworth C, Lanes SF (2006) Pooled clinical trial analysis of tiotropium safety. Chest 130:1695–1703
Sørensen HT (1997) Regional administrative health registries as a resource in clinical epidemiology. Int J Risk Safety Med 10:1–22
Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46(3):263–268
Gaist D, Sørensen HT, Hallas J (1997) The Danish prescription registries Dan Med Bull 44(4):445–448
Thomsen RW, Riis A, Christensen S, Norgaard M, Sørensen HT (2006) Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: A Danish population-based cohort study Diabetes Care 29(4):805–810
Christensen S, Riis A, Norgaard M, et␣al. (2006) Perforated peptic ulcer: Use of pre-admission oral glucocorticoids and 30-day mortality. Aliment Pharmacol Ther 23(1):45–52
Sørensen HT, Mellemkjaer L, Skriver MV, Lash TL, Olsen JH, Baron JA (2005) No excess risk of breast cancer among female users of systemic glucocorticoids Cancer Epidemiol Biomarkers Prev 14(4):1022–1023
Capella D (1993) Descriptive tools and analysis WHO Reg Publ Eur Ser 45:55–78
de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods J Clin Epidemiol 56(3):221–229
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40(5):373–383
Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287(5462):2398–2399
SAS Institute Inc., Cary, North Carolina
Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Olser M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56(2):124–130
Rothman KJ, Greenland S (eds). Modern Epidemiology, 2nd ed. Philadelphia, PA: Lippencott-Raven, 1998: 126–132
Acknowledgements
This study was jointly funded by Pfizer, Inc. and Boehringer-Ingelheim Pharmaceuticals, Inc. The health care databases at the Department of Clinical Epidemiology, Aarhus University Hospital are supported by the Western Danish Research Forum for Health Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Luise, C., Lanes, S.F., Jacobsen, J. et al. Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol 22, 267–272 (2007). https://doi.org/10.1007/s10654-007-9106-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-007-9106-5